Molecular Therapy Core Centers

The summary for the Molecular Therapy Core Centers grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Molecular Therapy Core Centers: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications for Core Center Grants to support molecular therapy research to develop treatments for cystic fibrosis and other genetic diseases of interest to NIDDK. Core Centers will provide shared resources to enhance the efficiency of research and foster collaborations within and among institutions with strong existing base of research relevant to gene transfer and gene correction technologies. Centers will also support a Pilot and Feasibility Program and an Educational Enrichment Program. This program is intended to foster research toward the goal of developing molecular therapies for the treatment of cystic fibrosis. Therefore, applicants should propose a central focus on molecular therapy for cystic fibrosis. Centers should also have a focus on development of new approaches for gene transfer and achieving gene correction. Many common principles are involved in the development of safe methods for targeting and achieving long- term expression of therapeutic genes for most genetic disease. Therefore, Core Center resources may also be made available to scientists developing gene therapy and gene correction approaches for genetic endocrine, metabolic, digestive, liver, kidney, urologic, and hematologic diseases.
Federal Grant Title: Molecular Therapy Core Centers
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DK-02-034
Type of Funding: Grant
CFDA Numbers: 93.847
CFDA Descriptions: Diabetes, Endocrinology and Metabolism Research
Current Application Deadline: No deadline provided
Original Application Deadline: Feb 13, 2003
Posted Date: Sep 16, 2002
Creation Date: Mar 15, 2003
Archive Date: Mar 15, 2003
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Individuals For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster NIH OER Webmaster
Similar Government Grants
Limited Competition for the Continuation of the Scientific Data Research Center (SDRC) for...
Limited Competition for the Continuation of Clinical Centers to Investigate the Pathogene...
Limited Competition for Continuation of the Integrated Islet Distribution Program (U24 Cli...
Limited Competition for the Continuation of the Urinary Stone Disease Research Network (US...
Limited Competition for the Continuation of the Urinary Stone Disease Research Network (US...
Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
Pilot and Feasibility Program in Human Islet Biology
Diabetes Endocrinology Research Centers
More Grants from the National Institutes of Health
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource...
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24)...
New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Tria... is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2022